CATHERINE DULAK, M.D.
Gynecology Physician in CORPUS CHRISTI, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
CATHERINE DULAK, M.D. filed 1,514 Medicare Part D claims in 2023 as a Gynecology Physician in CORPUS CHRISTI, Texas, prescribing 79% generic.
- 2K
- Part D claims, 2023
- 79%
- generic prescribing
- $26.7
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
CATHERINE DULAK, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
1,514 Top 19% higher than 81% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
CATHERINE DULAK, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about CATHERINE DULAK, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Texas
How Gynecology Physician compares to other specialties among Texas providers
Gynecology Physician share within Texas
Gynecology Physician is one of the more visible NUCC categories in Texas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Gynecology Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Gynecology Physician ABMS/AOA estimate
Est. board-certified rate (Gynecology Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Gynecology Physician US NPIs
Specialty board-certified rate — Gynecology Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
CATHERINE DULAK, M.D. appears in the CMS NPPES registry as a Gynecology Physician provider holding M.D. credentials at 5920 SARATOGA BLVD, CORPUS CHRISTI, TX, 78414, with a listed phone of (361) 985-6111. NPI 1356545271 was issued on 06/13/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DULAK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,514 prescription claims written by this provider, covering 362 Medicare beneficiaries and totaling roughly $134K in drug spend, split 21% brand-name and 79% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Gynecology Physician is a narrow specialty nationwide, with 3,902 enrolled providers across 53 states and an average of 295 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1356545271 |
|---|---|
| Specialty | Gynecology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 06/13/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm CATHERINE DULAK, M.D.'s current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CATHERINE DULAK, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$27
Largest payer
MILLICENT US INC
Most common payment type
Education
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Texas TMB 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to CATHERINE DULAK, M.D.. To verify CATHERINE DULAK, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
21% brand-name claims vs 79% generic, on 1,514 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,289
- Total Day Supply
- 60,165
- Brand vs Generic
- 21% brand / 79% generic
- Brand Drug Cost
- $107K
- Generic Drug Cost
- $27K
- Antibiotic Claims
- 76
Patient Demographics
- Average Patient Age
- 71.1 years
- Avg HCC Risk Score
- 0.91
- Age Distribution
- <65: 25, 65-74: 240, 75-84: 83, 85+: 14
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What CATHERINE DULAK, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Estradiol
Estradiol
209 claims
- Myrbetriq
Myrbetriq
117 claims
- Synthroid
Synthroid
97 claims
- Fluconazole
Fluconazole
91 claims
- Alendronate Sodium 69
Alendronate Sodium
69 claims
- Nystatin 63
Nystatin
63 claims
- Levothyroxine Sodium 59
Levothyroxine Sodium
59 claims
- Fluocinonide 57
Fluocinonide
57 claims
| Drug | Claims |
|---|---|
| Estradiol | 209 |
| Myrbetriq Mirabegron | 117 |
| Synthroid Levothyroxine Sodium | 97 |
| Fluconazole | 91 |
| Alendronate Sodium | 69 |
| Nystatin | 63 |
| Levothyroxine Sodium | 59 |
| Fluocinonide | 57 |
| Terconazole | 53 |
| Ciprofloxacin Hcl | 52 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Gynecology Physician Overview
How CATHERINE DULAK, M.D. fits within the Gynecology Physician landscape nationally.
CATHERINE DULAK, M.D.'s 1,514 claims are above the specialty average of 295.
Nearby Gynecology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as DULAK.
Compare Gynecology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is CATHERINE DULAK, M.D.'s specialty? ▼
How much does CATHERINE DULAK, M.D. prescribe under Medicare Part D? ▼
Where is CATHERINE DULAK, M.D. located? ▼
What is CATHERINE DULAK, M.D.'s NPI number? ▼
Does CATHERINE DULAK, M.D. prescribe more brand-name or generic drugs? ▼
How many Gynecology Physician providers are there in the US? ▼
What drugs does CATHERINE DULAK, M.D. prescribe most often? ▼
Does CATHERINE DULAK, M.D. accept Medicare? ▼
How can I verify CATHERINE DULAK, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology